Lu Daopei Hematology Hospital
| 中国 | トルコ | オーストリア | |
| 骨髄移植術 | から $55,000 | から $36,000 | から $140,000 |
| 非血縁者間同種骨髄移植術 | から $82,000 | から $80,000 | から $180,000 |
| 血漿交換術 | から $2,200 | から $1,200 | から $2,000 |
| 白血病化学療法 | から $16,500 | から $8,000 | から $15,000 |
| 生物学的療法 | から $5,800 | から $5,500 | から $20,000 |
Bookimedは血液腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。血液腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。血液腫瘍科治療の旅路でお一人になることはありません。
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
China integrates Traditional Chinese Medicine (TCM) into oncology through a dual-track system combining Western surgery or chemotherapy with herbal restorative care. This multidisciplinary model aims to eliminate tumors while rebuilding the immune system. Between 64% and 80% of Chinese cancer patients use TCM during treatment.
Bookimed Expert Insight: While many expect TCM to be an alternative, China's elite Class A Level III hospitals, like Yanda International, treat it as a mandatory clinical standard. Data shows these top-tier centers use TCM to stabilize blood counts faster after intensive procedures. Patients should prioritize JCI-accredited facilities to ensure herbal potency is strictly regulated alongside Western diagnostics.
Patient Consensus: Patients note that TCM is culturally essential in China and helps make side effects from treatments like rituximab feel much milder. However, they emphasize the need to monitor liver function closely when using herbal formulas alongside active chemotherapy.
Doctors in China assess hematology-oncology treatment using blood tests, medical imaging, and bone marrow biopsies. These tests track tumor shrinkage and blood cell normalization. Specialized centers like Lu Daopei Hematology Hospital use high-volume data to monitor response. They focus on cellular recovery and genetic markers.
Bookimed Expert Insight: Quality signals in China often correlate with hospital scale and specialized focus. Lu Daopei Hematology Hospital manages 200,000 patients annually across 30 departments. This massive volume allows doctors like Dr. Lu Peihua to recognize subtle response patterns faster. Large-scale facilities often provide quicker test turnarounds than smaller general clinics.
Patient Consensus: Patients note that physical signs like improved energy and reduced bruising often appear before laboratory shifts. They emphasize that regular blood draws are the primary way doctors track early progress between major scans.
International patients typically require an S1 or S2 Private Affairs visa for oncology treatment in China. The S2 visa covers stays under 180 days for surgeries. The S1 visa is for longer treatments exceeding 180 days. Both versions require an official invitation from a government-accredited hospital.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital or Xiamen Humanity Hospital handle over 1,000,000 patients annually. These Class A Level 3 facilities have dedicated departments to streamline visa invitations. This institutional support is vital because they can help convert initial entry visas into medical residency permits once treatment begins.
Patient Consensus: Patients note that hospital-sponsored invitations are more reliable than standard tourist visas for long oncology stays. They emphasize that while some enter on tourist visas, upgrading internally is necessary to avoid deportation during intensive treatment cycles.
English-speaking support in Chinese hematology oncology centers varies significantly by facility type. Top-tier institutions like Fuda Cancer Hospital and Yanda International Hospital hold JCI accreditation. These centers frequently provide dedicated international departments. Staff in these wings often speak English to assist the 30,000+ international patients treated annually.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital manage over 2,500,000 patients annually. Our data shows these `Class A level III` clinics are the most likely to have formal translation infrastructure. If you choose a specialized center like Lu Daopei, we recommend confirming support in writing before your stay. This ensures complex hematology protocols are clearly understood by all parties.
Patient Consensus: Patients note that while top doctors may speak basic English, daily care often requires translation apps like Pleco. It is helpful to prepare Mandarin terms for specific conditions like neutropenia or chemotherapy side effects before arrival.
Patients should plan to stay in China for 3 to 10 weeks for hematology-oncology care. Initial evaluations typically take 3 to 7 days. Advanced treatments like CAR-T cell therapy require 4 to 10 weeks for cell engineering and post-infusion monitoring.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital and Xiamen Humanity Hospital manage over 1,000,000 patients annually. This massive scale allows JCI-accredited facilities to offer thousands of modern technologies and drug trials that may not be available elsewhere. Patients should verify their specific treatment regimen early, as initial plans can change once on-site diagnostics are completed by specialists like Dr. Lu Peihua.
Patient Consensus: Patients emphasize budgeting an extra 2 weeks for potential appointment backlogs and recovery delays. It is highly recommended to hire a Mandarin-speaking medical translator and arrange long-term apartment housing near the hospital for comfort.
Family members can generally stay with you in Chinese hematology-oncology facilities. Policies vary by hospital type and room category. International-standard centers like Fuda Cancer Hospital offer more flexibility. Specialized units have stricter rules to protect immuno-compromised patients. General visiting hours usually run from 8 a.m. to 8 p.m.
Bookimed Expert Insight: Data from high-volume centers like Yanda International Hospital, which serves 2,500,000 patients annually, shows a preference for integrated care. Facilities with JCI accreditation typically offer better infrastructure for families. If family presence is your priority, look for clinics with over 1,000 beds. These larger campuses often include on-site hotel apartments or specialized family lounges.
Patient Consensus: Patients note that while standard rooms have strict night-time exits, paying for the family bed add-on makes a huge difference. Many families find it most practical to rent nearby apartments for long-term chemotherapy sessions to avoid hospital exhaustion.
Patients can obtain a remote second opinion for hematology oncology before traveling to China. Leading facilities like Fuda Cancer Hospital and Lu Daopei Hematology Hospital offer these services. Consultations typically use secure video platforms or written reports to validate diagnoses and treatment strategies before international travel.
Bookimed Expert Insight: Clinics with high patient volumes, such as Yanda International Hospital with 2,500,000 annual visits, often employ internal translation teams. These facilities seamlessly bridge language gaps for international cases. Choosing a JCI-accredited center like Fuda Cancer Hospital ensures that your remote consultation follows globally recognized safety and quality standards.
Patient Consensus: Patients note that sending pathology slides ahead via courier is vital for accurate remote analysis. Many find that using English-speaking coordinators helps navigate language barriers when uploading records to Chinese oncology platforms.